Melanoma and Other Skin Cancers

5 protocols meet the specified criteria.
  • A151804

    Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
  • EAY191

    Molecular Analysis for Combination Therapy Choice (ComboMATCH)
  • EAY191-A3

    A ComboMATCH Treatment Trial: Palbociclib and Binimetinib in RAS-Mutant Cancer
  • EAY191-N5

    A Randomized Trial of Neratinib, A Pan-ErbB Inhibitor, Alone or in Combination with Palbociclib, A CDK4/6 Inhibitor, in Patients with HER2+ Gynecologic Cancers and Other Solid Tumors - A ComboMATCH Treatment Trial
  • R3767-ONC-22122

    A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab In Participants with Unresectable or Metastatic Melanoma